Endothelium-specific CYP2J2 overexpression attenuates age-related insulin resistance.
Endothelium-specific CYP2J2 overexpression attenuates age-related insulin resistance.
复制标题
作者:
Yang Y;Dong R;Chen Z;Hu D;Fu M;Tang Y;Wang DW;Xu X;Tu L
Ample evidences demonstrate that cytochrome P450 epoxygenase‐derived epoxyeicosatrienoic acids (EETs) exert diverse biological activities, which include potent vasodilatory, anti‐inflammatory, and cardiovascular protective effects. In this study, we investigated the effects of endothelium‐specific CYP2J2 overexpression on age‐related insulin resistance and metabolic dysfunction. Endothelium‐specific targeting of the human CYP epoxygenase, CYP2J2, transgenic mice (Tie2‐CYP2J2‐Tr mice) was utilized. The effects of endothelium‐specific CYP2J2 overexpression on aging‐associated obesity, inflammation, and peripheral insulin resistance were evaluated by assessing metabolic parameters in young (3 months old) and aged (16 months old) adult male Tie2‐CYP2J2‐Tr mice. Decreased insulin sensitivity and attenuated insulin signaling in aged skeletal muscle, adipose tissue, and liver were observed in aged adult male mice, and moreover, these effects were partly inhibited in 16‐month‐old CYP2J2‐Tr mice. In addition, CYP2J2 overexpression‐mediated insulin sensitization in aged mice was associated with the amelioration of inflammatory state. Notably, the aging‐associated increases in fat mass and adipocyte size were only observed in 16‐month‐old wild‐type mice, and CYP2J2 overexpression markedly prevented the increase in fat mass and adipocyte size in aged Tie2‐CYP2J2‐Tr mice, which was associated with increased energy expenditure and decreased lipogenic genes expression. Furthermore, these antiaging phenotypes of Tie2‐CYP2J2‐Tr mice were also associated with increased muscle blood flow, enhanced active‐phase locomotor activity, and improved mitochondrial dysfunction in skeletal muscle. Collectively, our findings indicated that endothelium‐specific CYP2J2 overexpression alleviated age‐related insulin resistance and metabolic dysfunction, which highlighted CYP epoxygenase‐EET system as a potential target for combating aging‐related metabolic disorders.
登录
查看更多内容
影响因子:
7.8
作者:
Akasaki Y;Ouchi N;Izumiya Y;Bernardo BL;Lebrasseur NK;Walsh K
通讯作者:
Walsh K
影响因子:
3.9
作者:
Palmer, Allyson K.;Kirkland, James L.
通讯作者:
Kirkland, James L.
DOI:
10.1161/hypertensionaha.114.03884
发表时间:
2014-12
期刊:
Hypertension (Dallas, Tex. : 1979)
影响因子:
--
作者:
Abraham NG;Sodhi K;Silvis AM;Vanella L;Favero G;Rezzani R;Lee C;Zeldin DC;Schwartzman ML
通讯作者:
Schwartzman ML
DOI:
10.1124/jpet.111.180505
发表时间:
2011-11-01
影响因子:
3.5
作者:
Liu, Liu;Chen, Chen;Wang, Dao Wen
通讯作者:
Wang, Dao Wen
影响因子:
7.3
作者:
Batchu, S. N.;Lee, S. B.;Seubert, J. M.
通讯作者:
Seubert, J. M.